Poor iron status is not associated with overweight or overfat in non-obese pre-menopausal women

Journal of the American College of Nutrition

Volumn 28, Issue 1, 2009, Pages 37-42

  Karl, J Philip ^a   Lieberman, Harris R ^a   Cable, Sonya J ^b   Williams, Kelly W ^b   Glickman, Ellen L ^a   Young, Andrew J ^a   McClung, James P ^a  

^a U S ARMY RESEARCH INSTITUTE OF ENVIRONMENTAL MEDICINE   (United States)

^b Experimentation and Analysis Element   (United States)

Author keywords

Body fat; Iron; Iron deficiency; Obesity

Indexed keywords

FERRITIN; IRON; TRANSFERRIN; TUMOR NECROSIS FACTOR ALPHA; TRANSFERRIN RECEPTOR;

ADIPOSE TISSUE; ADULT; ARTICLE; BLOOD; BODY COMPOSITION; BODY MASS; COHORT ANALYSIS; ERYTHROCYTE; FEMALE; HUMAN; INFLAMMATION; METABOLISM; NUTRITIONAL STATUS; OBESITY; PATHOPHYSIOLOGY; PREMENOPAUSE; SKINFOLD THICKNESS; STATISTICAL MODEL; BODY FAT DISTRIBUTION; CELLULAR DISTRIBUTION; CONTROLLED STUDY; DISEASE ASSOCIATION; FERRITIN BLOOD LEVEL; IRON DEFICIENCY; LOGISTIC REGRESSION ANALYSIS; NORMAL HUMAN; RISK FACTOR;

ADIPOSE TISSUE; ADIPOSITY; BODY COMPOSITION; BODY MASS INDEX; COHORT STUDIES; ERYTHROCYTES; FEMALE; FERRITINS; HUMANS; INFLAMMATION; IRON; LOGISTIC MODELS; NUTRITIONAL STATUS; OVERWEIGHT; PREMENOPAUSE; SKINFOLD THICKNESS; TRANSFERRIN; TUMOR NECROSIS FACTOR-ALPHA; YOUNG ADULT;

EID: 69449092273     PISSN: 07315724     EISSN: 15411087     Source Type: Journal    
DOI: 10.1080/07315724.2009.10719759     Document Type: Article

References (32)

1. DeMaeyer E, els-Tegman M: The prevalence of anaemia in the world. World Health Stat Q 38:302–316, 1985.
2. Beard J, Tobin B: Iron status and exercise. Am J Clin Nutr 72:594S–597S, 2000.
3. Dallman PR: Biochemical basis for the manifestations of iron deficiency. Annu Rev Nutr 6:13–40, 1986.
4. Haas JD, Brownlie T: Iron deficiency and reduced work capacity: a critical review of the research to determine a causal relationship. J Nutr 131:676S–688S, 2001.
5. Zimmermann MB, Hurrell RF: Nutritional iron deficiency. Lancet 370:511–520, 2007.
6. Wenzel BJ, Stults HB, Mayer J: Hypoferraemia in obese adolescents. Lancet 2:327–328, 1962.
7. Pinhas-Hamiel O, Newfield RS, Koren I, Agmon A, Lilos P, Phillip M: Greater prevalence of iron deficiency in overweight and obese children and adolescents. Int J Obes Relat Metab Disord 27:416–418, 2003.
8. Nead KG, Halterman JS, Kaczorowski JM, Auinger P, Weitzman M: Overweight children and adolescents: a risk group for iron deficiency. Pediatrics 114:104–108, 2004.
9. Menzie CM, Yanoff LB, Denkinger BI, McHugh T, Sebring NS, Calis KA, Yanovski JA: Obesity-related hypoferremia is not explained by differences in reported intake of heme and nonheme iron or intake of dietary factors that can affect iron absorption. J Am Diet Assoc 108:145–148, 2008.
10. Yanoff LB, Menzie CM, Denkinger B, Sebring NG, McHugh T, Remaley AT, Yanovski JA: Inflammation and iron deficiency in the hypoferremia of obesity. Int J Obes 31:1412–1419, 2007.
11. Lecube A, Carrera A, Losada E, Hernandez C, Simo R, Mesa J: Iron deficiency in obese postmenopausal women. Obesity 14: 1724–1730, 2006.
12. Chambers EC, Heshka S, Gallagher D, Wang J, Pi-Sunyer FX, Pierson RN, Jr: Serum iron and body fat distribution in a multiethnic cohort of adults living in New York City. J Am Diet Assoc 106:680–684, 2006.
13. Lukaski HC: Vitamin and mineral status: effects on physical performance. Nutrition 20:632–644, 2004.
14. McClung JP, Marchitelli LJ, Friedl KE, Young AJ: Prevalence of iron deficiency and iron deficiency anemia among three populations of female military personnel in the US Army. J Am Coll Nutr 25:64–69, 2006.
15. Failla ML, Kennedy ML, Chen ML: Iron metabolism in genetically obese (ob/ob) mice. J Nutr 118:46–51, 1988.
16. Kennedy ML, Failla ML, Smith JC, Jr: Influence of genetic obesity on tissue concentrations of zinc, copper, manganese and iron in mice. J Nutr 116:1432–1441, 1986.
17. Zimmermann MB, Zeder C, Muthayya S, Winichagoon P, Chaouki N, Aerberli I, Hurrell RF: Adiposity in women and children from transition countries predicts decreased iron absorption, iron deficiency and a reduced response to iron fortification. Int J Obes 32:1098–1104, 2008.
18. Prentice AM, Jebb SA: Beyond body mass index. Obes Rev 2:141–147, 2001.
19. Jackson AS, Pollock ML, Ward A: Generalized equations for predicting body density of women. Med Sci Sports Exerc 12:175–181, 1980.
20. Heyward VH: Evaluation of body composition. Current Issues. Sports Med. 22:146–156, 1996.
21. World Health Organization: Obesity: preventing and managing the global epidemic. Technical report series 894. Geneva, 2000.
22. National Institutes of Health: Clinical Guidelines on the Identification, Evaluation, and Treatment of Overweight and Obesity in Adults. NIH Publication No. 98-4083. U.S. Department of Health and Human Services, 1998.
23. McClung JP, Karl JP: Iron deficiency and obesity: the contribution of inflammation and diminished iron absorption. Nutr Rev 67:100–104, 2009.
24. Centers for Disease Control and Prevention: Iron Deficiency-United States, 1999–2000. MMWR 51:897–899, 2002.
25. Greenberg AS, Obin MS: Obesity and the role of adipose tissue in inflammation and metabolism. Am J Clin Nutr 83:461S–465S, 2006.
26. Mena NP, Esparza A, Tapia V, Valdes P, Nunez MT: Hepcidin inhibits apical iron uptake in intestinal cells. Am J Physiol Gastrointest Liver Physiol 294:G192–G198, 2008.
27. Knutson MD, Oukka M, Koss LM, Aydemir F, Wessling-Resnick M: Iron release from macrophages after erythrophagocytosis is up-regulated by ferroportin 1 overexpression and down-regulated by hepcidin. Proc Natl Acad Sci USA 102:1324–1328, 2005.
28. Bekri S, Gual P, Anty R, Luciani N, Dahman M, Ramesh B, Iannelli A, Staccini-Myx A, Casanova D, Ben-Amour I, Saint-Paul MC, Huet, PM, Sadoul JL, Gugenheim J, Srai SK, Tran A, Le Marchand-Brustel Y: Increased adipose tissue expression of hepcidin in severe obesity is independent from diabetes and NASH. Gastroenterology 131:788–796, 2006.
29. Baillie FJ, Morrison AE, Fergus I: Soluble transferrin receptor: a discriminating assay for iron deficiency. Clin Lab Haematol 25: 353–357, 2003.
30. Beguin Y: Soluble transferrin receptor for the evaluation of erythropoiesis and iron status. Clin Chim Acta 329:9–22, 2003.
31. Kemna EH, Tjalsma H, Podust VN, Swinkels DW: Mass spectrometry-based hepcidin measurements in serum and urine: analytical aspects and clinical implications. Clin Chem 53:620–628, 2007.
32. Kemna EH, Tjalsma H, Willems HL, Swinkels DW: Hepcidin: from discovery to differential diagnosis. Haematologica 93:90–97, 2008.